Skip to main content
Rafael Holdings, Inc. logo

Rafael Holdings, Inc. — Investor Relations & Filings

Ticker · RFL ISIN · US75062C1009 US Professional, scientific and technical activities
Open in API
Filings indexed 393 across all filing types
Latest filing 2022-03-03 Capital/Financing Update
Country US United States of America
Listing US RFL

About Rafael Holdings, Inc.

https://rafaelholdings.com

Rafael Holdings, Inc. is a clinical-stage biotechnology company that invests in and develops therapies for difficult-to-treat diseases. The company holds interests in early-stage and clinical pharmaceutical entities, with a primary focus on novel cancer therapeutics aimed at improving and extending the lives of patients. Following a merger with Cyclo Therapeutics, Rafael Holdings is also advancing a potential breakthrough treatment for Niemann-Pick Type C1, a rare genetic disorder.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2022
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-3. It references the Securities Act of 1933 and discusses procedural acknowledgments related to the registration statement's effectiveness. There is no financial data, report content, or detailed disclosures typical of financial reports. The document is a regulatory communication related to a capital raising registration statement, specifically a request for acceleration of effectiveness. This fits the category of Capital/Financing Update (CAP), as it pertains to the registration and timing of securities issuance.
2022-03-03 English
AMENDMENT NO. 1 TO FORM S-3
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 1 to a Registration Statement on Form S-3 filed with the SEC. It is a regulatory filing related to securities registration under the Securities Act of 1933. The text includes references to incorporation by reference of other SEC filings such as Form 10-K, 10-Q/A, and 8-K, but the document itself is not a financial report or earnings release. It is a formal amendment to a registration statement, which is a type of regulatory filing. The document length is over 12,000 characters, indicating it is a substantive filing, not a brief announcement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-03-02 English
AMENDMENT NO. 1 TO FORM 10-Q
Interim / Quarterly Report Q1 2022
2022-02-28 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 28, 2022, by Rafael Holdings, Inc. It reports a non-reliance on previously issued unaudited consolidated interim financial statements for the quarter ended October 31, 2021, due to material misstatements and internal control weaknesses. The filing discusses restatement plans and changes in management's conclusions about internal controls. The document is a current report disclosing a significant event related to financial reporting and internal controls, not a full annual or quarterly report itself. It is not an earnings release, audit report, or management discussion but a regulatory filing informing investors of the restatement and control issues. Therefore, it fits best under Regulatory Filings (RNS) as a current report (Form 8-K) disclosing material information about financial restatements and internal control weaknesses.
2022-02-28 English
FORM RW
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the SEC requesting withdrawal of a previously filed Registration Statement on Form S-4. It is not a financial report or detailed filing but a formal regulatory communication about the withdrawal of a registration statement related to a business combination that will not be consummated. The document is short (1767 characters) and serves as a regulatory notice rather than a report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2022-02-24 English
Regulatory Filings 2022
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Due to the lack of identifiable information and the inability to determine the nature of the document, it cannot be classified into any specific filing category. According to the fallback rule, such documents should be classified as Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but the content is not interpretable.
2022-02-22 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.